Southern Home Medical Reports Positive Earnings and Expects to Achieve 200% Increase in the Coming Year with Several New Developments and New Products
Mar 27, 2017
OTC Disclosure & News Service
-
Southern Home Medical Reports Positive Earnings and Expects to Achieve 200% Increase in the Coming Year with Several New Developments and New Products
NEW YORK, NY--(Marketwired - Mar 27, 2017) - Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer in the Healthcare Industry, has announced today that as a result of the new mergers the company has reported positive earnings in revenue for the year of 2016. With several new developments and new products the firm would expect to achieve 200% increase in coming year.
With the cooperation and assistance of Dr. Zhongzheng Liu, who has made many breakthroughs involving precision medicine, and the US Government's "Precision Medicine Initiative," Precision Medicine will have a massive future potential. It's modeled to create $607 billion in health benefits in the short timeframe of 50 years.
The firm's other focus is the Stem Cell; the Chinese stem cell market forecast is as follows: Cardiovascular patients: 240 million, diabetes patients: 41.6 million, Alzheimer patients: 14.6 million, and up to 30 billion by 2020.
George Chang, Chief Executive Officer: "While we are exceeding our expectations month-after-month in terms of revenues and net income, we are working on more cooperation, new developments and more products for the company. We will continue this trend and increase our shareholder value year after year. We have strong confidence that the firm will achieve far better revenue and net income from those new signed cooperation, new developments and new products."
About Southern Home Medical, Inc.:
Southern Home Medical, Inc. is a Holding Company with a focus on servicing the needs of the Healthcare Industry. SHOM will continue to leverage the success of their businesses in order to expand sales opportunities in other locations throughout the country with health, medical and equipment needs.
Could actually be around $25MM + in sales.
Mar 27, 2017
OTC Disclosure & News Service
-
Southern Home Medical Reports Positive Earnings and Expects to Achieve 200% Increase in the Coming Year with Several New Developments and New Products
NEW YORK, NY--(Marketwired - Mar 27, 2017) - Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer in the Healthcare Industry, has announced today that as a result of the new mergers the company has reported positive earnings in revenue for the year of 2016. With several new developments and new products the firm would expect to achieve 200% increase in coming year.
With the cooperation and assistance of Dr. Zhongzheng Liu, who has made many breakthroughs involving precision medicine, and the US Government's "Precision Medicine Initiative," Precision Medicine will have a massive future potential. It's modeled to create $607 billion in health benefits in the short timeframe of 50 years.
The firm's other focus is the Stem Cell; the Chinese stem cell market forecast is as follows: Cardiovascular patients: 240 million, diabetes patients: 41.6 million, Alzheimer patients: 14.6 million, and up to 30 billion by 2020.
George Chang, Chief Executive Officer: "While we are exceeding our expectations month-after-month in terms of revenues and net income, we are working on more cooperation, new developments and more products for the company. We will continue this trend and increase our shareholder value year after year. We have strong confidence that the firm will achieve far better revenue and net income from those new signed cooperation, new developments and new products."
About Southern Home Medical, Inc.:
Southern Home Medical, Inc. is a Holding Company with a focus on servicing the needs of the Healthcare Industry. SHOM will continue to leverage the success of their businesses in order to expand sales opportunities in other locations throughout the country with health, medical and equipment needs.
Could actually be around $25MM + in sales.
